For instance, a dual-ligand nanoparticle targeting EGFR and αvβ3 integrin can achieve a nearly 2-fold higher deposition into breast cancer metastasis in the lungs than its single-ligand nanoparticle counterparts [19]. The gene discussed is EGFR; the disease is breast carcinoma.